S
Seres Therapeutics, Inc. (MCRB)
NMS – Real vaqt narxi. Valyuta: USD
4.72
+0.08 (1.72%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
4.72
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
4.72
+0.08 (1.72%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
4.72
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $56.6M naqd pul zahiralaridan ($15.6M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $42.3M jami joriy majburiyatlardan $20.0M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (1.6) tarmoq o'rtachasidan ancha yuqori bo'lib, haddan tashqari leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$22.4M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 2.11 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 2.11 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 1.64 | 0.30 | 4.0 | |
| Qarz/Aktivlar nisbati | 0.56 | 1.04 | 4.0 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 5.8 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 7M | N/A | N/A | 789K | 2M |
| Yalpi foyda | -5M | -15M | -15M | -3M | -2M |
| Operatsion daromad | -245M | -195M | -118M | -94M | -77M |
| Sof foyda | -250M | -114M | -147M | 6M | -22M |
| EBITDA | -234M | -180M | -103M | -90M | -74M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 1709.12 | -206.91 | 5.5 |
| Keyingi chorak | N/A | 42.98 | 5.5 |
| Joriy yil | 1648.67 | -649.22 | 5.5 |
| Keyingi yil | -98.02 | -40.68 | 1.0 |
| O‘rtacha ball | 4.4 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 105.59 | 123.01 | 122.6 | -36.87 | 7.8 |
| Yil/Yil | 999 | 123.07 | 120.7 | -66.24 | 7.8 |
| 3 yil o‘rtacha | 632.67 | 43.19 | 386.82 | 43.06 | 10 |
| 5 yil o‘rtacha | 427.85 | -25.08 | 195.07 | -1593.12 | 5.5 |
| O‘rtacha ball | 7.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |